1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Vanguard Health Care Fund Buys Ironwood Pharmaceuticals Inc., Johnson & Johnson, Boston Scientific Corp., Sells Amylin Pharmaceuticals Inc., Mead Johnson Nutrition, Novartis Ag

Vanguard Health Care Fund Q1 Portfolio: Buys IRWD, JNJ, BSX

Edward Owens manages Vanguard Health Care Fund. Since inception in 1984, his fund has gained 16.8% a year. The fund lost more than 3% this year. These are the first quarter portfolio update of his fund.

Edward Owens buys Ironwood Pharmaceuticals Inc., sells Ims Health Inc. during the 3-months ended 03/31/2010, according to the most recent filings of his investment company, Vanguard Health Care Fund. Edward Owens owns 79 stocks with a total value of $18.5 billion. These are the details of the buys and sells.

For the details of Edward Owens's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Edward+Owens

This is the sector weightings of his portfolio:

Health Care 61.4%
Consumer Services 8%
Technology 1.5%
Industrials 0.8%
Financials 0.6%
Consumer Goods 0.1%


These are the top 5 holdings of Edward Owens

  1. Merck & Co. Inc. (MRK) - 33,630,248 shares, 6.78% of the total portfolio. Shares reduced by 0.88%
  2. Forest Laboratories Inc. (FRX) - 29,933,000 shares, 5.07% of the total portfolio. Shares reduced by 0.66%
  3. Pfizer Inc (PFE) - 43,259,788 shares, 4.01% of the total portfolio.
  4. McKesson Corp. (MCK) - 11,189,900 shares, 3.97% of the total portfolio.
  5. Eli Lilly And Company (LLY) - 19,879,900 shares, 3.89% of the total portfolio.


Added: Johnson & Johnson (NYSE:JNJ)

Edward Owens added to his holdings in Johnson & Johnson by 47.06%. His purchase prices were between $62.37 and $65.36, with an estimated average price of $63.98. The impact to his portfolio due to this purchase was 0.56%. His holdings were 5,000,000 shares as of 03/31/2010.

Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnson & Johnson has a market cap of $174.75 billion; its shares were traded at around $63.4 with a P/E ratio of 13.6 and P/S ratio of 2.8. The dividend yield of Johnson & Johnson stocks is 3.1%. Johnson & Johnson had an annual average earning growth of 11.1% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 4.5-star.

Added: Boston Scientific Corp. (NYSE:BSX)

Edward Owens added to his holdings in Boston Scientific Corp. by 119.57%. His purchase prices were between $6.8 and $9.62, with an estimated average price of $8.14. The impact to his portfolio due to this purchase was 0.43%. His holdings were 20,200,000 shares as of 03/31/2010.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. Boston Scientific Corp. has a market cap of $9.99 billion; its shares were traded at around $6.59 with a P/E ratio of 10.7 and P/S ratio of 1.3. Boston Scientific Corp. had an annual average earning growth of 5.4% over the past 10 years.

New Purchase: Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)

Edward Owens initiated holdings in Ironwood Pharmaceuticals Inc.. His purchase prices were between $11.5 and $14.63, with an estimated average price of $13.03. The impact to his portfolio due to this purchase was 0.15%. His holdings were 2,000,000 shares as of 03/31/2010.

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. Ironwood Pharmaceuticals Inc. has a market cap of $231.5 million; its shares were traded at around $12.08 .

Reduced: Amylin Pharmaceuticals Inc. (AMLN)

Edward Owens reduced to his holdings in Amylin Pharmaceuticals Inc. by 11.38%. His sale prices were between $22.67 and $22.95, with an estimated average price of $22.81. The impact to his portfolio due to this sale was -0.02%. Edward Owens still held 1,557,200 shares as of 03/31/2010.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin Pharmaceuticals Inc. has a market cap of $2.66 billion; its shares were traded at around $18.54 with and P/S ratio of 3.6.

Reduced: Novonordisk A/s (NYSE:NVO)

Edward Owens reduced to his holdings in Novonordisk A/s by 12.5%. His sale prices were between $63.85 and $79.13, with an estimated average price of $71.13. The impact to his portfolio due to this sale was -0.04%. Edward Owens still held 700,000 shares as of 03/31/2010.

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Novonordisk A/s has a market cap of $49.39 billion; its shares were traded at around $79.66 with and P/S ratio of 5.1. The dividend yield of Novonordisk A/s stocks is 1.2%.

Reduced: Mead Johnson Nutriti (NYSE:MJN)

Edward Owens reduced to his holdings in Mead Johnson Nutriti by 21.12%. His sale prices were between $43.62 and $52.35, with an estimated average price of $47.55. The impact to his portfolio due to this sale was -0.12%. Edward Owens still held 2,068,137 shares as of 03/31/2010.

Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutriti has a market cap of $9.86 billion; its shares were traded at around $48.2 with a P/E ratio of 20.9 and P/S ratio of 3.5. The dividend yield of Mead Johnson Nutriti stocks is 1.9%.

Reduced: Osi Pharmaceuticals Inc. (OSIP)

Edward Owens reduced to his holdings in Osi Pharmaceuticals Inc. by 13.02%. His sale prices were between $30.92 and $60.06, with an estimated average price of $42.79. The impact to his portfolio due to this sale was -0.14%. Edward Owens still held 3,340,873 shares as of 03/31/2010.

Osi Pharmaceuticals is one of the pharmaceutical research and development organizations, commercializing its skills in drug discovery, preclinical research, and drug development. Osi Pharmaceuticals Inc. has a market cap of $3.34 billion; its shares were traded at around $57.33 with a P/E ratio of 27.2 and P/S ratio of 7.7.

Reduced: Novartis Ag (NYSE:NVS)

Edward Owens reduced to his holdings in Novartis Ag by 27.16%. His sale prices were between $51.91 and $55.52, with an estimated average price of $54.06. The impact to his portfolio due to this sale was -0.49%. Edward Owens still held 6,169,880 shares as of 03/31/2010.

Novartis AG is committed to improving health and well-being through innovative products and services. Novartis Ag has a market cap of $109.72 billion; its shares were traded at around $48.31 with a P/E ratio of 13.1 and P/S ratio of 2.6. The dividend yield of Novartis Ag stocks is 3.4%. Novartis Ag had an annual average earning growth of 14.2% over the past 10 years. GuruFocus rated Novartis Ag the business predictability rank of 5-star.


Rating: 2.0/5 (11 votes)

Comments

Please leave your comment:


GuruFocus Mobile App Available


Select portfolio(s):

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK